The most common side effects of Ozempic (semaglutide) are gastrointestinal: nausea, vomiting, diarrhea, abdominal pain, and constipation. In clinical trials, roughly one in three people taking Ozempic experienced some form of digestive upset, compared to about 15% of those on placebo. Most of these symptoms are temporary, peaking in the first few weeks and fading as your body adjusts. But Ozempic also carries rarer, more serious risks worth understanding before you start or increase your dose.
Nausea, Vomiting, and Other Digestive Symptoms
Nausea is the single most reported side effect. At the 0.5 mg dose, about 16% of people in trials experienced it. At 1 mg, that number rose to 20%, compared to just 6% on placebo. Vomiting followed a similar pattern: 5% at the lower dose, 9% at the higher one. Diarrhea affected roughly 8.5 to 9% of users regardless of dose, while constipation hit about 5% at the lower dose and tapered slightly at the higher one.
These symptoms are most noticeable during two windows: when you first start the medication and after each dose increase. The majority of nausea and vomiting reports in clinical trials occurred during the dose escalation phase. For most people, symptoms are mild to moderate and fade within the first four weeks at a given dose. A small percentage of users, around 3 to 4%, find the digestive side effects severe enough to stop taking the medication entirely.
Why These Symptoms Happen
Ozempic works by mimicking a hormone called GLP-1, which your gut naturally releases after eating. One of its effects is slowing down how quickly your stomach empties food into your small intestine. This is part of how it reduces appetite and helps control blood sugar, but it also explains why your digestive system can feel sluggish, bloated, or unsettled, especially early on. Your stomach simply isn’t used to holding food that long.
Delayed Stomach Emptying and Gastroparesis
In some cases, the slowed stomach emptying goes beyond mild discomfort. Gastroparesis, a condition where the stomach takes far too long to move food through, has been reported in Ozempic users. One study in healthy volunteers found that 50% experienced measurably delayed gastric emptying while on a GLP-1 drug. In more severe cases, food has been found sitting in the stomach more than 24 hours after a meal.
The line between the drug’s intended effect and gastroparesis isn’t always clear. The same mechanism that suppresses hunger and controls blood sugar can, in some people, slow the stomach to the point of persistent nausea, vomiting, bloating, and feeling full after just a few bites. If digestive symptoms worsen rather than improve over time, that’s a signal worth raising with your prescriber rather than waiting it out.
Gallbladder Problems
Ozempic and similar drugs increase the risk of gallstones and gallbladder inflammation. Large analyses pooling data from dozens of clinical trials have consistently found that people taking GLP-1 drugs face roughly 28 to 37% higher risk of gallbladder disease compared to those not taking them. In one study of 308 patients on various GLP-1 drugs, nearly a third developed gallstones, and among semaglutide users specifically, 68% of those gallstone cases were symptomatic.
Gallstone symptoms typically include sudden, intense pain in the upper right abdomen or center of the abdomen, sometimes radiating to the back or right shoulder. The pain often comes on after eating, particularly after fatty meals, and can last from minutes to several hours. Rapid weight loss itself is a known trigger for gallstone formation, so the combination of the drug’s direct effects and significant weight loss may compound the risk.
Kidney Injury From Dehydration
Severe nausea, vomiting, and diarrhea can lead to dehydration, and dehydration can cause a rapid decline in kidney function. Cases of acute kidney injury have been reported in Ozempic users, typically in people whose gastrointestinal symptoms were particularly intense. The pattern is straightforward: persistent vomiting depletes fluids and electrolytes, blood volume drops, and the kidneys can’t filter properly.
People with existing kidney disease are at higher risk because they have less reserve to absorb the hit. If you’re experiencing multiple days of significant vomiting or diarrhea, staying hydrated isn’t just comfort advice. It’s the difference between a rough week and a trip to the emergency room.
Pancreatitis
Acute pancreatitis, inflammation of the pancreas, is a rare but serious risk. In the large SUSTAIN 6 trial, nine patients on semaglutide developed it compared to 12 on placebo, suggesting the absolute risk is low. However, many researchers believe cases may be underreported because people taking Ozempic often have other pancreatitis risk factors like obesity and long-standing diabetes.
The hallmark symptom is severe pain in the upper abdomen, often radiating straight through to the back. It typically comes on suddenly and is accompanied by vomiting. In reported cases tied to semaglutide, symptoms appeared anywhere from two months to years after starting the drug, sometimes triggered by a recent dose increase. One documented case involved a patient who had been stable on semaglutide for four years before a dose increase from 0.25 to 0.5 mg led to worsening nausea and constipation, followed by continuous vomiting and severe pancreatitis.
Vision Changes in People With Diabetes
If you have type 2 diabetes and existing eye damage from the disease, Ozempic can temporarily worsen it. In the SUSTAIN 6 trial, retinopathy complications occurred in 3% of semaglutide users compared to 1.8% on placebo, a 76% relative increase in risk.
This isn’t unique to Ozempic. It’s a known consequence of rapidly improving blood sugar control. When blood sugar drops quickly after being elevated for a long time, the small blood vessels in the retina can react poorly in the short term. The worsening typically appeared within the first 16 weeks of treatment. For people with diabetes who already have some degree of retinopathy, eye exams before and during treatment can catch changes early.
The Thyroid Cancer Warning
Ozempic carries the FDA’s most serious warning label, a boxed warning, related to thyroid cancer. In animal studies, semaglutide caused thyroid C-cell tumors in rodents. Whether this translates to humans remains unknown. Because of this uncertainty, Ozempic is contraindicated for anyone with a personal or family history of medullary thyroid carcinoma or a genetic condition called Multiple Endocrine Neoplasia syndrome type 2.
Symptoms to be aware of include a lump or mass in the neck, difficulty swallowing, shortness of breath, or persistent hoarseness. These are worth flagging immediately, though they can also have many benign causes.
Managing Side Effects in Practice
Most people can reduce digestive symptoms through straightforward changes to how and what they eat. Smaller meals every three hours or so tend to work better than two or three larger ones, since your stomach is emptying more slowly than usual. Bland foods like crackers, toast, rice, and soup are easier to tolerate when nausea is active. Fatty, fried, and heavily spiced foods tend to make things worse.
Gentle movement after eating, even a short walk, can help food move through your digestive system more comfortably. Staying well hydrated matters more on Ozempic than it might otherwise, especially during the early weeks or after a dose increase when vomiting and diarrhea are most likely. The goal is to get through the adjustment period, which for most people means the first few weeks at each new dose, with minimal disruption to daily life. If symptoms aren’t improving or are getting worse after several weeks, that’s a meaningful signal rather than something to push through.